Ligand Pharmaceuticals Inc (LGND)
R&D Expenses
$41.35M
TTM · Period ending: · USD
LGND R&D Expenses
Latest reported$41.35Mperiod ending
Latest reported$41.35Mperiod ending
LGND TTM R&D Expenses ($0.00 → $41.35M)
TTM R&D Expenses
High-resolution chart · PNG
LGND r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 41,346,000 | |
| 33,245,000 | |
| 81,182,000 | |
| 82,096,000 | |
| 66,752,000 | |
| 65,539,000 | |
| 21,425,000 | |
| 22,488,000 | |
| 22,345,000 | |
| 23,845,000 | |
| 24,537,000 | |
| -6,330,000 | |
| -2,623,000 | |
| -1,010,000 | |
| 1,506,000 | |
| 45,128,000 | |
| 52,827,000 | |
| 60,313,000 | |
| 69,013,000 | |
| 72,686,000 | |
| 68,601,000 | |
| 65,380,000 | |
| 59,392,000 | |
| 56,140,000 | |
| 57,029,000 | |
| 56,510,000 | |
| 55,908,000 | |
| 46,084,000 | |
| 37,825,000 | |
| 31,747,000 | |
| 27,865,000 | |
| 27,658,000 | |
| 26,934,000 | |
| 25,621,000 | |
| 26,887,000 | |
| 24,662,000 | |
| 26,208,000 | |
| 25,893,000 | |
| 21,224,000 | |
| 17,686,000 | |
| 13,919,000 | |
| 13,422,000 | |
| 13,380,000 | |
| 13,709,000 | |
| 14,192,000 | |
| 12,871,000 | |
| 12,040,000 | |
| 11,215,000 | |
| 10,608,000 | |
| 9,941,000 | |
| 9,275,000 | |
| 9,377,000 | |
| 9,610,000 | |
| 10,438,000 | |
| 10,790,000 | |
| 10,912,000 | |
| 10,736,000 | |
| 11,123,000 | |
| 10,292,000 | |
| 10,849,000 | |
| 13,313,000 | |
| 16,678,000 | |
| 22,054,000 | |
| 29,025,000 | |
| 34,011,000 | |
| 36,879,000 | |
| 39,979,000 | |
| 40,916,000 | |
| 37,160,000 | |
| 34,067,000 | |
| 30,770,000 | |
| 30,139,000 | |
| 33,812,000 | |
| 36,186,000 | |
| 44,623,000 | |
| 47,104,000 | |
| 47,734,000 | |
| 52,878,000 | |
| 49,494,000 | |
| 50,486,000 | |
| 52,929,000 | |
| 53,558,000 | |
| 56,075,000 | |
| 54,368,000 | |
| 59,437,000 | |
| 63,087,000 | |
| 65,204,000 | |
| 69,489,000 | |
| 69,205,000 | |
| 67,890,000 | |
| 67,678,000 | |
| 67,565,000 | |
| 65,510,000 | |
| 62,332,000 | |
| 58,807,000 | |
| 55,063,000 | |
| 52,304,000 | |
| 51,814,000 | |
| 51,104,000 | |
| 51,285,000 |